Aloprim

This page contains recent news articles, when available, and an overview of Aloprim but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

2008-07-03 03:29:17 - www.companiesandmarkets.com adds new report ...  -  02 Jul 2008
The company markets Nabi-HB for postexposure prevention of hepatitis B infection and Aloprim for the treatment of chemotherapy-induced hyperuricemia. PR-Inside.com (Pressemitteilung),

Allopurinol: What You Need to Know  -  Nov 4, 2007
Allopurinol -- which goes by the brand names Aloprim and Zyloprim -- is a drug that belongs to a class of medications called xanthine oxidase inhibitors. About - News & Issues,

wallstreetstockreview.com: Breaking News from Gemini Explorations ...  -  Nov 12, 2007
It markets Nabi-HB for post-exposure prevention of hepatitis B infection and Aloprim for the treatment of chemotherapy-induced hyperuricemia. Trading Markets (press release),

Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial ...  -  Aug 1, 2007
CNNMoney.comRecent Accomplishments April: -- Executed a definitive agreement to sell Aloprim(TM) (allopurinol sodium) for Injection to Bioniche Teoranta for $3.7

Nabi Biopharmaceuticals Announces Results of 2007 Annual Meeting ...  -  May 18, 2007
PR Newswire (press release),Nabi also announced today that it has completed the sale of its Aloprim(TM) (allopurinol sodium) for Injection product. The company received $1.3 million at

Nabi Biopharmaceuticals Announces Agreement to Sell Aloprim  -  Apr 20, 2007
PharmaLive.com (press release),The aggregate sale proceeds for Aloprim is $3.7 million -- Nabi will receive $1.3 million at closing, $1.4 million at the end of 2007 and $1.0 million at

Nabi sells Aloprim for $3.7M  -  Apr 19, 2007
South Florida Business Journal,The Boca Raton-based biotech had bought Aloprim, which treats chemotherapy-induced hyperuricemia (a high level of uric acid in the blood),

Nabi to Sell Aloprim to Bioniche  -  Apr 19, 2007
Houston Chronicle,NEW YORK — Nabi Biopharmaceuticals said Thursday it will sell its gout treatment Aloprim to Ireland-based Bioniche Teoranta, part of the Bioniche Pharma

Nabi Biopharma (NABI) Sells Aloprim  -  Apr 19, 2007
StreetInsider.com (subscription),Nabi Biopharmaceuticals (Nasdaq: NABI) executed a definitive agreement to sell its Aloprim for Injection product to Bioniche Teoranta.

Nabi to sell Aloprim injection product to Bioniche Teoranta  -  Apr 19, 2007
ReutersO: Quote, Profile, Research) said it agreed to sell its Aloprim for injection product for cancer patients to Ireland-based Bioniche Teoranta for $3.7

RoundTable Healthcare Partners Facilitates Product Acquisition for ...  -  Apr 19, 2007
PR Newswire (press release),Aloprim for Injection is indicated for the management of patients with leukemia, lymphoma, and solid-tumor malignancies who are receiving cancer therapy

Nabi to sell drug to Irish pharmaceutical firm  -  Apr 20, 2007
Charlotte Business Journal,Nabi Biopharmaceuticals is selling off its Aloprim drug to an Irish company as part of its move to restructure the company.

Market Report -- In Play (NABI)  -  Apr 19, 2007
MSN MoneyNABI Biopharma announces agreement to sell Aloprim Co announces it has executed a definitive agreement to sell its Aloprim (allopurinol sodium) for

Business Topics by Industry  -  Apr 20, 2007
Sun-Sentinel.com,Boca Raton-based Nabi Biopharmaceuticals plans to sell its Aloprim injectable drug to inhibit the formation of uric acid in chemotherapy patients for $3.7

Bioniche Pharma Acquires Nabi Product  -  Apr 20, 2007
Private Equity Hub,Bioniche Pharma Group Ltd., an Ireland–based maker of injectable generic drugs, has agreed to acquire Aloprim for Injection from Nabi Biopharmaceuticals for

Nabi Biopharmaceuticals Files Form 10-K and Corrects Financial Tables  -  Apr 6, 2007
Drug Newswire (press release),The company has two products on the market today: Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], and Aloprim(TM) (allopurinol sodium) for Injection.

Nabi Biopharmaceuticals Announces Initiation of Civacir(R) Phase ...  -  Jan 17, 2007
Drug Newswire (press release),The company has two products on the market today: Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], and Aloprim(TM) (allopurinol sodium) for Injection.

:
 
Web health.mongabay.com


Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

mongabay.com


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.


COPYRIGHT 2007 MONGABAY.COM